Skip to main content
Free research Free research Free target review with research home and workspace preview
Quick search ChEMBL 36
Loading Target Snapshot...
Querying ChEMBL database. This may take a few seconds.
Target Snapshot

CHEMBL2390812 Target Snapshot

G protein-coupled receptor GPR35 · SINGLE PROTEIN · Rattus norvegicus

47Compounds
4Assays
2Approved Drugs
29.0Activities
Free Research Context

Research home keeps recent targets

This target will appear in recent viewed items on this browser. Use the demo workspace to preview watch rules and decision queues.

Navigation

Switch target

Move to another high-traffic target or paste a specific ChEMBL target ID.

Broader Open DB context

Frame the target before identity details

Structured disease, protein, and project context should read before the lower-level identity rail.

As of 2026-09-13

Protein identity stays anchored to UniProt Q33BM1. Use UniProt Q33BM1 as the stable identity anchor, then attach disease evidence before program review.

Review focus
Protein anchor ready

Use UniProt Q33BM1 as the stable identity anchor, then attach disease evidence before program review.

ChEMBL component mapping + Open Targets-ready proxy + ChEMBL 36 via Core Engine 2026-09-13
Open source guide
Identity Layer

Cross-source identity

Keep the review anchor, source IDs, and context contract aligned before reusing this target elsewhere.

This review treats G protein-coupled receptor GPR35 as ChEMBL target CHEMBL2390812, mapped to UniProt Q33BM1. Disease framing currently uses the Open Targets-ready proxy contract.

Review anchor
G protein-coupled receptor GPR35
SINGLE PROTEIN · Rattus norvegicus
As of 2026-09-13
ChEMBL target ID
CHEMBL2390812
Primary anchor for compounds, assays, approvals, and exports
ChEMBL 36 via Core Engine As of 2026-09-13
www.ebi.ac.uk
UniProt accession
Q33BM1
G protein-coupled receptor GPR35
UniProt accession via ChEMBL component mapping As of 2026-09-13
www.uniprot.org
Disease evidence contract
Open Targets-ready proxy
ChEMBL drug mechanism + indication proxy
ChEMBL drug mechanism + indication proxy As of 2026-09-13
www.ebi.ac.uk

Reuse the same identifiers in notes, watch rules, exports, and review packs so provenance stays stable across surfaces.

Source Guidance

Start with the right source

Choose the first block or source based on the question you are trying to answer.

Need stable target naming and protein identity?
UniProt Target Context
UniProt accession via ChEMBL component mapping

Start here when your first question is whether G protein-coupled receptor GPR35 is the right protein anchor across sources, using UniProt Q33BM1 as the stable mapping.

Jump to Protein Context
Need disease fit before discussing compounds?
Disease Relevance & Evidence Level
ChEMBL drug mechanism + indication proxy

Use this block first when you need the strongest disease program and evidence level in one place.

Jump to Disease Context
Need a meeting-ready explanation of why this target matters?
Evidence Card
Review-ready rationale with source-aware context

Open the one-page evidence card when you want the rationale, activity base, and attribution together.

Open Review-ready Card
Overview

Basic Information

Verify identity, organism, and the fastest next research jumps from the same page.

UniProt Context

UniProt Target Context

Reviewable protein naming and mapping context for this target snapshot.

Protein LabelG protein-coupled receptor GPR35
UniProt AccessionQ33BM1
Component TypeProtein
Sequence Length306 aa

G protein-coupled receptor GPR35

Source · UniProt accession via ChEMBL component mapping
Review Cue

How to read this target

Review this target as G protein-coupled receptor GPR35, mapped to UniProt Q33BM1. Sequence length is 306 aa.

Mapped IDQ33BM1
Review nameG protein-coupled receptor GPR35
OrganismRattus norvegicus
Clinical Profile

Clinical Phase Distribution

2
Approved
1
Phase II
1
Phase I
Assay Mix

Activity Type Distribution

EC5029.0
Lead Set

Top Inhibitors (by pChEMBL)

ChEMBL IDpChEMBLTypeValue (nM)Phase
CHEMBL28079 7.21 EC50 61.1 Clinical
CHEMBL1201198 7.02 EC50 95.0 Approved
CHEMBL74 6.01 EC50 986.0 Approved
CHEMBL2392183 6.0 EC50 991.0 Preclinical
CHEMBL2392176 5.96 EC50 1100.0 Preclinical
CHEMBL2392148 5.92 EC50 1200.0 Preclinical
CHEMBL2392177 5.89 EC50 1300.0 Preclinical
CHEMBL2392175 5.87 EC50 1360.0 Preclinical
CHEMBL2392174 5.85 EC50 1400.0 Preclinical
CHEMBL2392182 5.81 EC50 1540.0 Preclinical
Distribution

pChEMBL Value Distribution

5
5.0
19
5.5
2
6.0
0
6.5
2
7.0
0
7.5
0
8.0
0
8.5
0
9.0
0
9.5
pChEMBL
Approved Drugs

Approved Drugs

PEMIROLAST
CHEMBL1201198
Approved 1999
CROMOLYN SODIUM
CHEMBL74
Approved 1982
Assay Landscape

Assay Landscape

4
Total Assays
28
Tested Compounds
2
Assay Types
Binding — 3 assays, 28 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 3 28 5.7
Functional — 1 assays, 1 compounds
BAO Format Assays Compounds Avg pChEMBL
cell-based format 1 1 7.0

Confidence Score Distribution

Source · ChEMBL 36 via Core Engine